EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group

Philipp Karschnia iD, Jacob S Young, Antonio Dono iD, Levin Häni, Tommaso Sciortino, Francesco Bruno iD, Stephanie T Juenger, Nico Teske, Ramin A Morshed, Alexander F Haddad, Yalan Zhang, Sophia Stoecklein und 16 weitere

Neuro-Oncology · 04.05.2023 · 25 (5) · 940-954

DOI: 10.1093/neuonc/noac193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 12.08.2022. Verfasst von Philipp Karschnia und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 388-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Terminology to describe extent of resection in glioblastoma is inconsistent across clinical trials. A surgical classification system was previously proposed based upon residual contrast-enhancing (CE) tumor. We aimed to (1) explore the prognostic utility of the classification system and (2) define how much removed non-CE tumor translates into a survival benefit.

Methods

The international RANO resect group retrospectively searched previously compiled databases from 7 neuro-oncological centers in the USA and Europe for patients with newly diagnosed glioblastoma per WHO 2021 classification. Clinical and volumetric information from pre- and postoperative MRI were collected.

Results

We collected 1,008 patients with newly diagnosed IDHwt glioblastoma. 744 IDHwt glioblastomas were treated with radiochemotherapy per EORTC-26981/22981 (TMZ/RT→TMZ) following surgery. Among these homogenously treated patients, lower absolute residual tumor volumes (in cm3) were favorably associated with outcome: patients with “maximal CE resection” (class 2) had superior outcome compared to patients with “submaximal CE resection” (class 3) or “biopsy” (class 4). Extensive resection of non-CE tumor (≤5 cm3 residual non-CE tumor) was associated with better survival among patients with complete CE resection, thus defining class 1 (“supramaximal CE resection”). The prognostic value of the resection classes was retained on multivariate analysis when adjusting for molecular and clinical markers.

Conclusions

The proposed “RANO categories for extent of resection in glioblastoma” are highly prognostic and may serve for stratification within clinical trials. Removal of non-CE tumor beyond the CE tumor borders may translate into additional survival benefit, providing a rationale to explicitly denominate such “supramaximal CE resection.”

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansPrognosisRetrospective StudiesNeurosurgical ProceduresTreatment Outcome

Stichwörter der Autor:innen

EORclassificationglioblastomaoutcomesurgical resection

Autor:innen und Institutionen

  • Department of Neurosurgery, Ludwig-Maximilians-University, Munich, Germany.
  • German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.
  • Department of Neurosurgery & Division of Neuro-Oncology, University of San Francisco, San Francisco, California,USA.
  • Department of Neurosurgery, McGovern Medical School at UT Health Houston , Houston, Texas, USA.
  • Department of Neurosurgery, University of Freiburg , Freiburg, Germany.
  • Division for Neuro-Oncology, Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

ORCID-Profile: Philipp Karschnia, Antonio Dono, Francesco Bruno, Michael Weller, Nitin Tandon, Annette M Molinaro, Yoshua Esquenazi, Mitchel S Berger

Förderung

  • NCI NIH HHS

Zitieren

APA

Karschnia, P., Young, J. S., Dono, A., Häni, L., Sciortino, T., Bruno, F., Juenger, S. T., Teske, N., Morshed, R. A., Haddad, A. F., Zhang, Y., Stoecklein, S., Weller, M., Vogelbaum, M. A., Beck, J., Tandon, N., Hervey-Jumper, S., Molinaro, A. M., Rudà, R., …, & Tonn, J. C. (2023). Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro-Oncology, 25(5), 940-954. https://doi.org/10.1093/neuonc/noac193

Vancouver

Karschnia P, Young JS, Dono A, Häni L, Sciortino T, Bruno F, et al. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro-Oncology. 2023;25(5):940-954. doi:10.1093/neuonc/noac193

BibTeX
@article{Karschnia2023,
  author = {Karschnia, Philipp and Young, Jacob S and Dono, Antonio and Häni, Levin and Sciortino, Tommaso and Bruno, Francesco and Juenger, Stephanie T and Teske, Nico and Morshed, Ramin A and Haddad, Alexander F and Zhang, Yalan and Stoecklein, Sophia and Weller, Michael and Vogelbaum, Michael A and Beck, Juergen and Tandon, Nitin and Hervey-Jumper, Shawn and Molinaro, Annette M and Rudà, Roberta and Bello, Lorenzo and Schnell, Oliver and Esquenazi, Yoshua and Ruge, Maximilian I and Grau, Stefan J and Berger, Mitchel S and Chang, Susan M and van den Bent, Martin and Tonn, Joerg-Christian},
  title = {Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group},
  journal = {Neuro-Oncology},
  year = {2023},
  volume = {25},
  number = {5},
  pages = {940--954},
  doi = {10.1093/neuonc/noac193}
}
Kostenlos starten →